Oncology Institute (TOI) Competitors $3.73 +0.06 (+1.63%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$3.78 +0.05 (+1.34%) As of 08/1/2025 07:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock TOI vs. AHCO, AGL, PNTG, AVAH, CDNA, SBC, PSNL, FLGT, INNV, and CELCShould you be buying Oncology Institute stock or one of its competitors? The main competitors of Oncology Institute include AdaptHealth (AHCO), Agilon Health (AGL), The Pennant Group (PNTG), Aveanna Healthcare (AVAH), CareDx (CDNA), SBC Medical Group (SBC), Personalis (PSNL), Fulgent Genetics (FLGT), InnovAge (INNV), and Celcuity (CELC). These companies are all part of the "healthcare" industry. Oncology Institute vs. Its Competitors AdaptHealth Agilon Health The Pennant Group Aveanna Healthcare CareDx SBC Medical Group Personalis Fulgent Genetics InnovAge Celcuity AdaptHealth (NASDAQ:AHCO) and Oncology Institute (NASDAQ:TOI) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, media sentiment, earnings, institutional ownership, analyst recommendations, risk, valuation and profitability. Does the media refer more to AHCO or TOI? In the previous week, Oncology Institute had 2 more articles in the media than AdaptHealth. MarketBeat recorded 6 mentions for Oncology Institute and 4 mentions for AdaptHealth. Oncology Institute's average media sentiment score of 1.23 beat AdaptHealth's score of 0.94 indicating that Oncology Institute is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AdaptHealth 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Oncology Institute 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has stronger valuation and earnings, AHCO or TOI? AdaptHealth has higher revenue and earnings than Oncology Institute. Oncology Institute is trading at a lower price-to-earnings ratio than AdaptHealth, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAdaptHealth$3.26B0.36$90.42M$0.5715.35Oncology Institute$403.15M0.83-$64.66M-$0.70-5.33 Do institutionals and insiders believe in AHCO or TOI? 82.7% of AdaptHealth shares are held by institutional investors. Comparatively, 36.9% of Oncology Institute shares are held by institutional investors. 1.6% of AdaptHealth shares are held by company insiders. Comparatively, 8.5% of Oncology Institute shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Do analysts rate AHCO or TOI? AdaptHealth currently has a consensus price target of $13.40, indicating a potential upside of 53.14%. Oncology Institute has a consensus price target of $7.00, indicating a potential upside of 87.67%. Given Oncology Institute's stronger consensus rating and higher possible upside, analysts plainly believe Oncology Institute is more favorable than AdaptHealth.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score AdaptHealth 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00Oncology Institute 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33 Is AHCO or TOI more profitable? AdaptHealth has a net margin of 2.63% compared to Oncology Institute's net margin of -15.38%. AdaptHealth's return on equity of 6.96% beat Oncology Institute's return on equity.Company Net Margins Return on Equity Return on Assets AdaptHealth2.63% 6.96% 2.40% Oncology Institute -15.38%-445.02%-34.13% Which has more volatility and risk, AHCO or TOI? AdaptHealth has a beta of 1.58, meaning that its share price is 58% more volatile than the S&P 500. Comparatively, Oncology Institute has a beta of 0.02, meaning that its share price is 98% less volatile than the S&P 500. SummaryAdaptHealth beats Oncology Institute on 10 of the 17 factors compared between the two stocks. Get Oncology Institute News Delivered to You Automatically Sign up to receive the latest news and ratings for TOI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TOI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TOI vs. The Competition Export to ExcelMetricOncology InstituteMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$327.49M$7.18B$5.48B$9.51BDividend YieldN/A2.90%4.73%4.08%P/E Ratio-5.3364.1328.6723.80Price / Sales0.8334.25373.9066.65Price / CashN/A25.7735.4557.96Price / Book74.608.618.275.55Net Income-$64.66M$239.96M$3.24B$259.03M7 Day Performance1.36%-5.48%-3.69%-4.59%1 Month Performance52.87%-3.73%4.33%4.46%1 Year Performance592.15%18.27%25.95%18.03% Oncology Institute Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TOIOncology Institute2.407 of 5 stars$3.73+1.6%$7.00+87.7%+578.2%$327.49M$403.15M-5.33660AHCOAdaptHealth4.0736 of 5 stars$9.15-0.8%$13.40+46.4%-21.2%$1.24B$3.26B16.0510,500Positive NewsUpcoming EarningsAGLAgilon Health1.6467 of 5 stars$2.15+1.2%$4.71+119.8%-74.2%$877.58M$6.06B-3.641,076Upcoming EarningsPNTGThe Pennant Group3.5791 of 5 stars$23.24-0.8%$33.80+45.4%-26.2%$807.61M$695.24M30.587,000Upcoming EarningsAVAHAveanna Healthcare1.499 of 5 stars$4.03+1.8%$5.25+30.3%-10.1%$772.57M$2.02B201.5033,500News CoverageUpcoming EarningsGap UpCDNACareDx4.1685 of 5 stars$12.75+7.1%$29.33+130.1%-48.2%$663.44M$346.42M11.09740Positive NewsUpcoming EarningsAnalyst DowngradeHigh Trading VolumeSBCSBC Medical GroupN/A$5.22-7.6%N/AN/A$585.40M$205.42M0.00N/AHigh Trading VolumePSNLPersonalis3.8577 of 5 stars$6.20+0.2%$7.67+23.7%+51.0%$546.73M$84.61M-4.81400Upcoming EarningsGap DownFLGTFulgent Genetics4.1625 of 5 stars$17.75-0.2%$24.00+35.2%-21.4%$541.29M$283.47M-13.351,313News CoverageGap UpINNVInnovAge1.8099 of 5 stars$3.80-3.3%$5.00+31.6%-48.1%$530.60M$763.85M-16.522,350News CoverageCELCCelcuity0.8625 of 5 stars$13.54-0.4%$28.25+108.6%+122.5%$514.60MN/A-4.4740Insider TradeAnalyst Revision Related Companies and Tools Related Companies AdaptHealth Alternatives Agilon Health Alternatives The Pennant Group Alternatives Aveanna Healthcare Alternatives CareDx Alternatives SBC Medical Group Alternatives Personalis Alternatives Fulgent Genetics Alternatives InnovAge Alternatives Celcuity Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TOI) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredA new rule goes live in July — and the banks are quietly crushing itA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding The Oncology Institute, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oncology Institute With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
